LoginRegister
    Biohaven Pharma acute migraine drug Vazegepant succeeds in studyBiohaven Pharma acute migraine drug Vazegepant succeeds in study
    Purdue Pharma CEO bonus opposed by senatorsPurdue Pharma CEO bonus opposed by senators
    Discrepancies in documents submitted by Meril Life Science for exempting MeRes100 from price cap; NPPA stalls decisionDiscrepancies in documents submitted by Meril Life Science for exempting MeRes100 from price cap;...
    Hetero launches HIV drug Taffic in India post DCGI nodHetero launches HIV drug Taffic in India post DCGI nod
    Lupin arm Nanomi BV completes Kyowa divestiture to UnisonLupin arm Nanomi BV completes Kyowa divestiture to Unison
    GSK seeks USFDA nod for myeloma drug Belantamab MafodotinGSK seeks USFDA nod for myeloma drug Belantamab Mafodotin
    Sanofi Allegra shows positive results in phase 3 study for allergic rhinitisSanofi Allegra shows positive results in phase 3 study for allergic rhinitis
    Bayer appeals to reverse USD 25 million Roundup verdictBayer appeals to reverse USD 25 million Roundup verdict
    Medical Device Park: DoP to provide financial assistance to tune of Rs 25 crore; says MOS HealthMedical Device Park: DoP to provide financial assistance to tune of Rs 25 crore; says MOS Health
    Indian trademark rights, brand for anti-diabetic drug Vildagliptin acquired by CiplaIndian trademark rights, brand for anti-diabetic drug Vildagliptin acquired by Cipla
    Indoco Remedies Goa plant gets GMP certificate from UK health regulatorIndoco Remedies Goa plant gets GMP certificate from UK health regulator
    Pfizer, Astellas Pharma get USFDA nod for prostate cancer therapy XtandiPfizer, Astellas Pharma get USFDA nod for prostate cancer therapy Xtandi
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X